CN Stock MarketDetailed Quotes

688289 Sansure Biotech Inc.

Watchlist
  • 20.15
  • +0.41+2.08%
Market Closed May 31 15:00 CST
11.86BMarket Cap30.81P/E (TTM)

Sansure Biotech Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sansure Biotech Inc. Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 27, 2024

Revenue(YoY)

390.95M

+100.31%
EPS(YoY)

0.14

+40.00%
Analyst Rating

Strong Buy

Jun 1, 2024

Sansure Biotech Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.009B--
--2024/FY-- / 1.496B--
--2023/FY1.006B / ----
--2021/FY4.515B / 4.321B--
--2020/FY4.767B / 5.080B--
--2019/FY365.389M / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.009B--
--2024/FY-- / 1.496B--
--2023/FY1.006B / ----
--2021/FY4.515B / 4.321B--
--2020/FY4.767B / 5.080B--
--2019/FY365.389M / ----
--------
--------
--------
--------

Unlock Free Earnings Estimates

Sansure Biotech Inc. Earnings Reports

  • Shengxiang Biotechnology Co., Ltd. 2024 First Quarter Report

    Apr 26 12:00 ET

  • Summary of the 2023 Annual Report of Shengxiang Biotechnology Co., Ltd.

    Apr 26 12:00 ET

  • Full text of the 2023 annual report of Shengxiang Biotechnology Co., Ltd.

    Apr 26 12:00 ET

  • Announcement of Shengxiang Biotechnology Co., Ltd. on voluntary disclosure of the results forecast for the first quarter of 2024

    Apr 12 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 1, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg